hydrating and moisturizing cream

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

This entry describes glycerin as a polyol humectant for gels, emulsions, and washes, with a guide level rather than a batch result.

3. Typical use levels (formulation guide)

• For gels and serums, use 3–8% for the formula.
• The formulation record indicates 2–5% for creams for the formula.
• The formulation record indicates 2–4% for rinse-off as a formulation guide.

Add Glycerin to the water phase; no separate melt step is needed.

4. Regulatory sources & global compliance

• A CosIng listing for Glycerin provides ingredient information, not approval of a supplied grade or finished product.
• An EU-market cosmetic under Regulation (EC) No 1223/2009 requires a safety evaluation of the product containing Glycerin as it will be marketed for the complete formula intended for sale.
• Review the documentation for the actual Glycerin grade and the filing requirements for the target market.

5. Safety & risk assessment

Treat the listed amount as cosmetic-development guidance; no drug approval or OTC-monograph status follows from this guide and the completed cosmetic needs its own patch and stability checks.

6. Stability & packaging

Protect sealed bulk from warmth and direct light; take oxidation sensitivity into account when selecting the final pack; test the selected package with the confirmed batch for stability and fit.

7. Claims language (Do / Don’t)

• The recorded cosmetic positioning for Glycerin highlights humectant function.

• This reference does not demonstrate therapeutic effects, curative outcomes, or unsupported certification statements.
• The available details for Glycerin cannot establish whitening, acne-treatment, antiperspirant, sun-protection, or hair-growth benefits.

1. INCI & CAS

INCI: Squalane · CAS: 111-01-3

2. Role in the formula

As a hydrocarbon emollient, squalane offers stability; the grade in this guide is plant-derived rather than mineral oil.

3. Typical use levels (formulation guide)

• The stated reference for gel-creams is 2–6%.
• The formulation record indicates 10–30% for dry oils for the formula.
• Balms: 5–15% for the formula.

The oil phase is the addition point for Squalane, with no high-shear wax operation.

4. Regulatory sources & global compliance

• Treat any CosIng entry for Squalane as a reference only; verify the grade and intended use under current market rules.
• Regulation (EC) No 1223/2009 requires a safety assessment covering the complete formulation with Squalane at the level of the finished cosmetic product.
• Confirm the actual Squalane grade from supplier documentation and check requirements where the product will be sold.

5. Safety & risk assessment

Use the stated level as reference guidance for cosmetic formulation; it provides no evidence that a drug or OTC monograph applies with patch assessment and finished-formula stability testing still required.

6. Stability & packaging

Hold the bulk material in a sealed, cool place shielded from light; consider an airless or pump format when oxidation sensitivity warrants it; check the finished batch's stability and package compatibility.

7. Claims language (Do / Don’t)

• The recorded cosmetic positioning for Squalane highlights a light-emollient role.

• The development record does not establish drug or therapeutic claims, clinical cures, or certification claims not confirmed for the product.
• The formulation record for Squalane should not be used to substantiate skin whitening, acne care, sweat reduction, sun protection, or hair-growth outcomes.

1. INCI & CAS

INCI: Butyrospermum Parkii Butter · CAS: 91080-23-8

2. Role in the formula

The butter role is assigned to shea in creams, balms, and hair creams. The reference makes no assumption about unrefined color or scent.

3. Typical use levels (formulation guide)

• For creams, the recorded level is 2–8% for the formula.
• For balms and butters, use 10–25% as a formulation guide.

The process note calls for melting Butyrospermum Parkii Butter into oil and cooling with shear so the butter does not grain.

4. Regulatory sources & global compliance

• A CosIng listing for Butyrospermum Parkii Butter provides ingredient information, not approval of a supplied grade or finished product.
• Before EU placement, Regulation (EC) No 1223/2009 requires an assessment addressing the safety of the finished product that contains Butyrospermum Parkii Butter before the cosmetic is placed on the EU market.
• Review the documentation for the actual Butyrospermum Parkii Butter grade and the filing requirements for the target market.

5. Safety & risk assessment

This formulation note gives a cosmetic-use reference level; it provides no evidence that a drug or OTC monograph applies so assess patch response and stability in the final formula.

6. Stability & packaging

Maintain cool, closed, light-protected storage for the bulk material; if oxidation risk calls for it, review a pump or airless format; follow with stability and packaging checks on the confirmed batch.

7. Claims language (Do / Don’t)

• The cosmetic role of Butyrospermum Parkii Butter is presented as shea cushion.

• The development record cannot substantiate drug effects, clinical cures, or unsupported product certifications.
• This reference for Butyrospermum Parkii Butter does not support whitening, acne treatment, antiperspirant effects, sunscreen use, or hair growth.